top of page

South Africa’s (SAHPRA’s) updated Reliance Guideline for a New Registration or Variation Application

Writer: Sharan MuruganSharan Murugan

This guideline is intended to provide information and guidance to applicants/HCRs on the prescribed requirements and process to be followed, in cases where a new registration or variation application is submitted to SAHPRA with the applicant/HCR requesting a reliance-based evaluation.

The World Health Organisation defines reliance as “[t]he act whereby the regulatory authority in one jurisdiction may take into account and give significant weight to – i.e. totally or partially rely upon – evaluations performed by another regulatory authority or trusted institution in reaching its own decision.


The relying authority remains responsible and accountable for decisions taken, even when it relies on the decisions and information of others.” Wherever possible, SAHPRA will leverage these pathways, relying on the evaluation efforts of Recognised Regulatory Authorities (RRAs) in order to reduce evaluation times.


Reliance-based evaluation pathways for medicines applications for new registrations and variations in South Africa will follow one of three evaluation / review pathways:

a) Abridged review

b) Verified review

c) Recognition

For more information click on this LINK

Kommentare


I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page